{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:54:41Z","timestamp":1782849281399,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The IPF-PRO\/ILD-PRO Registry is supported by Boehringer Ingelheim Pharmaceuticals, Inc and run in collaboration with the Duke Clinical Research Institute and enrolling centers."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Pulmonary fibrosis may impair an individual\u2019s ability to work. We assessed the extent, cost and factors associated with workplace productivity loss among patients with progressive pulmonary fibrosis (PPF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The multi-center ILD-PRO Registry enrolled US patients with progressive interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis. Workplace productivity loss was assessed using the Work Productivity and Activity Impairment (WPAI) questionnaire. Associations between patient characteristics and workplace productivity loss among employed patients were analyzed using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 175 employed patients of 597 who completed the WPAI questionnaire, 58.3% were female, median age was 58 years, median forced vital capacity (FVC) was 58.7% predicted; 20.0% used oxygen with activity and at rest. In the past 7 days, mean (SD) hours worked was 32.9 (15.8) and mean (SD) working hours lost was 10 (12). Mean (SD) percentage of working hours lost was 24.4 (30.2). Mean (SD) working hours lost due to absenteeism and presenteeism were 4 (9) and 8 (11), respectively. Among patients with any productivity loss, the estimated mean (SD) annual cost of productivity loss was $24,815 ($17,917). Lower FVC % predicted, higher (worse) St. George\u2019s Respiratory Questionnaire scores and lower (worse) Cough and Sputum Assessment Questionnaire cough impact and symptoms scores were associated with greater odds of productivity loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with PPF showed significant impairment in workplace productivity. Worse lung function and worse scores on patient-reported outcomes were associated with a greater likelihood of productivity loss.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial Registration<\/jats:italic>\n                      ClinicalTrials.gov; No: NCT01915511; registered August 5, 2013;\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">URL: www.clinicaltrials.gov<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-026-00895-x","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:42:14Z","timestamp":1779889334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry"],"prefix":"10.1007","volume":"204","author":[{"given":"Sharashchandra","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-9971","authenticated-orcid":false,"given":"Aparna C.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peide","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-1081","authenticated-orcid":false,"given":"Megan L.","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-0412","authenticated-orcid":false,"given":"Amy L","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5962-2184","authenticated-orcid":false,"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ILD-PRO Registry investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Beegle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Chardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rany","family":"Condos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Dilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford","family":"Bemiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridu","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hajari","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hotchkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jad","family":"Kebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ena","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hewlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Pinto-Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph","family":"Lipchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LJason","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R.","family":"Luckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Mageto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby M.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lake","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Namen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessy","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Porteous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Strek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P. M.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"9","key":"895_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KC (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"895_CR2","doi-asserted-by":"publisher","first-page":"00681","DOI":"10.1183\/23120541.00681-2021","volume":"8","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek M, Molina-Molina M, Chassany O, Fox J, Galvin L, Geissler K, Hammitt KM, Kreuter M, Moua T, O\u2019Brien EC, Slagle AF, Krasnow A, Reaney M, Baldwin M, Male N, Rohr KB, Swigris J, Antoniou K (2022) Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Res 8(2):00681\u20132021. https:\/\/doi.org\/10.1183\/23120541.00681-2021","journal-title":"ERJ Open Res"},{"key":"895_CR3","doi-asserted-by":"publisher","first-page":"1067149","DOI":"10.3389\/fmed.2023.1067149","volume":"10","author":"R Takei","year":"2023","unstructured":"Takei R, Matsuda T, Fukihara J, Sasano H, Yamano Y, Yokoyama T, Kataoka K, Kimura T, Suzuki A, Furukawa T, Fukuoka J, Johkoh T, Kondoh Y (2023) Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis. Front Med (Lausanne) 10:1067149. https:\/\/doi.org\/10.3389\/fmed.2023.1067149","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"895_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12931-024-02897-w","volume":"25","author":"R Green","year":"2024","unstructured":"Green R, Baldwin M, Pooley N, Misso K, M\u00f6lken MPR, Patel N, Wijsenbeek MS (2024) The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis. Respir Res 25(1):325. https:\/\/doi.org\/10.1186\/s12931-024-02897-w","journal-title":"Respir Res"},{"issue":"2","key":"895_CR5","doi-asserted-by":"publisher","first-page":"2300752","DOI":"10.1183\/13993003.00752-2023","volume":"63","author":"M Wijsenbeek","year":"2024","unstructured":"Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, Baldwin M, Mueller H, Rohr KB, Flaherty KR, INBUILD Trial Investigators (2024) Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J 63(2):2300752. https:\/\/doi.org\/10.1183\/13993003.00752-2023","journal-title":"Eur Respir J"},{"issue":"3","key":"895_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1440-1843.2011.02122.x","volume":"17","author":"CJ Ryerson","year":"2012","unstructured":"Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR (2012) Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 17(3):525\u2013532. https:\/\/doi.org\/10.1111\/j.1440-1843.2011.02122.x","journal-title":"Respirology"},{"issue":"4","key":"895_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.36141\/svdld.v36i4.8418","volume":"36","author":"E Yaln\u0131z","year":"2019","unstructured":"Yaln\u0131z E, Polat G, Demirci F, Deniz S, Karadeniz G, Ayd\u0131nl\u0131 E, Vayisoglu G, Ayranc\u0131 A (2019) Are idiopathic pulmonary fibrosis patients more anxious and depressive than patients with other interstitial lung disease? Sarcoidosis Vasc Diffuse Lung Dis 36(4):294\u2013301. https:\/\/doi.org\/10.36141\/svdld.v36i4.8418","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"895_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.chest.2019.04.016","volume":"156","author":"M Algamdi","year":"2019","unstructured":"Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ (2019) Costs of workplace productivity loss in patients with fibrotic interstitial lung disease. Chest 156(5):887\u2013895. https:\/\/doi.org\/10.1016\/j.chest.2019.04.016","journal-title":"Chest"},{"issue":"9","key":"895_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1513\/AnnalsATS.201911-822OC","volume":"17","author":"M Algamdi","year":"2020","unstructured":"Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ (2020) Costs of workplace productivity loss in patients with connective tissue disease-associated interstitial lung disease. Ann Am Thorac Soc 17(9):1077\u20131084. https:\/\/doi.org\/10.1513\/AnnalsATS.201911-822OC","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"895_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/resp.14234","volume":"27","author":"M Knarborg","year":"2022","unstructured":"Knarborg M, L\u00f8kke A, Hilberg O, Ibsen R, Sikjaer MG (2022) Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: a nationwide population-based cohort study. Respirology 27(5):341\u2013349. https:\/\/doi.org\/10.1111\/resp.14234","journal-title":"Respirology"},{"issue":"1","key":"895_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12890-024-03247-8","volume":"24","author":"LJ Lobo","year":"2024","unstructured":"Lobo LJ, Liu Y, Li P, Ramaswamy M, Ramaswamy M, Swaminathan AC, Veeraraghavan S, Fan Y, Neely ML, Palmer SM, Olson AL, ILD-PRO Registry investigators (2024) Design and baseline characteristics of the ILD-PRO Registry in patients with progressive pulmonary fibrosis. BMC Pulm Med 24(1):468. https:\/\/doi.org\/10.1186\/s12890-024-03247-8","journal-title":"BMC Pulm Med"},{"issue":"5","key":"895_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 4(5):353\u2013365. https:\/\/doi.org\/10.2165\/00019053-199304050-00006","journal-title":"PharmacoEconomics"},{"key":"895_CR13","unstructured":"Reilly MC (2004) Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI:GH). http:\/\/www.reillyassociates.net\/wpai_gh.html"},{"key":"895_CR14","unstructured":"U.S. Bureau of Labor Statistics Median usual weekly earnings of full-time wage and salary workers by age and sex. Accessed via: https:\/\/www.bls.gov\/charts\/usual-weekly-earnings\/usual-weekly-earnings-current-quarter-by-age.htm. Accessed: 10 December 2024"},{"issue":"11","key":"895_CR15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.rmed.2008.06.009","volume":"102","author":"B Crawford","year":"2008","unstructured":"Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, Nivens C, Ghafouri M, McDonald J, Tetzlaff K (2008) Development and validation of a cough and sputum assessment questionnaire. Respir Med 102(11):1545\u20131555. https:\/\/doi.org\/10.1016\/j.rmed.2008.06.009","journal-title":"Respir Med"},{"key":"895_CR16","doi-asserted-by":"publisher","unstructured":"Jones PW, Quirk FH, Baveystock CM (1991) The St George\u2019s Respiratory Questionnaire. Respir Med 85 Suppl B 25\u201331. https:\/\/doi.org\/10.1016\/s0954-6111(06)80166-6","DOI":"10.1016\/s0954-6111(06)80166-6"},{"issue":"10","key":"895_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156(10):684\u2013691. https:\/\/doi.org\/10.7326\/0003-4819-156-10-201205150-00004","journal-title":"Ann Intern Med"},{"issue":"2","key":"895_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.rmed.2009.09.006","volume":"104","author":"JJ Swigris","year":"2010","unstructured":"Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, Wamboldt FS (2010) The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 104(2):296\u2013304. https:\/\/doi.org\/10.1016\/j.rmed.2009.09.006","journal-title":"Respir Med"},{"key":"895_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/COPD.S219480","volume":"15","author":"P Rebelo","year":"2020","unstructured":"Rebelo P, Oliveira A, Paix\u00e3o C, Valente C, Andrade L, Marques A (2020) Minimal clinically important differences for patient-reported outcome measures of cough and sputum in patients with COPD. Int J Chron Obstruct Pulmon Dis 15:201\u2013212. https:\/\/doi.org\/10.2147\/COPD.S219480","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"895_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jval.2016.12.006","volume":"20","author":"J Kigozi","year":"2017","unstructured":"Kigozi J, Jowett S, Lewis M, Barton P, Coast J (2017) The estimation and inclusion of presenteeism costs in applied economic evaluation: a systematic review. Value Health 20(3):496\u2013506. https:\/\/doi.org\/10.1016\/j.jval.2016.12.006","journal-title":"Value Health"},{"key":"895_CR21","doi-asserted-by":"publisher","unstructured":"Wuyts WA, Papiris S, Manali E, Kilpel\u00e4inen M, Davidsen JR, Miedema J, Robalo-Cordeiro C, Morais A, Art\u00e9s M, Asijee G, Cendoya D, Soulard S (2020) The burden of progressive fibrosing interstitial lung disease: a DELPHI approach. Adv Ther 2020;37(7):3246\u201364. https:\/\/doi.org\/10.1007\/s12325-020-01384-0","DOI":"10.1007\/s12325-020-01384-0"},{"issue":"12","key":"895_CR22","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1007\/s12325-023-02701-z","volume":"40","author":"A L\u00f8kke","year":"2023","unstructured":"L\u00f8kke A, Castello L, Pinheiro Martins P, Soulard S, Hilberg O (2023) Burden of disease and productivity loss in the European Economic Area in patients affected by fibrosing interstitial lung disease. Adv Ther 40(12):5502\u20135518. https:\/\/doi.org\/10.1007\/s12325-023-02701-z","journal-title":"Adv Ther"},{"issue":"4","key":"895_CR23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1007\/s12325-022-02066-9","volume":"39","author":"AL Olson","year":"2022","unstructured":"Olson AL, Hartmann N, Patnaik P, Garry EM, Bohn RL, Singer D, Baldwin M, Wallace L (2022) Healthcare resource utilization and related costs in chronic fibrosing interstitial lung diseases with a progressive phenotype: a US claims database analysis. Adv Ther 39(4):1794\u20131809. https:\/\/doi.org\/10.1007\/s12325-022-02066-9","journal-title":"Adv Ther"},{"issue":"8","key":"895_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.18553\/jmcp.2022.28.8.871","volume":"28","author":"D Singer","year":"2022","unstructured":"Singer D, Bengtson LGS, Conoscenti CS, Anderson AJ, Brekke L, Shetty SS, Brown KK (2022) Burden of illness in progressive fibrosing interstitial lung disease. J Manag Care Spec Pharm 28(8):871\u2013880. https:\/\/doi.org\/10.18553\/jmcp.2022.28.8.871","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"895_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.18553\/jmcp.2024.30.2.163","volume":"30","author":"M Nili","year":"2024","unstructured":"Nili M, Steffens A, Anderson A, Brekke L, Grace Johnson M, Veeranki P, Olson AL (2024) Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease type. J Manag Care Spec Pharm 30(2):163\u2013174. https:\/\/doi.org\/10.18553\/jmcp.2024.30.2.163","journal-title":"J Manag Care Spec Pharm"},{"key":"895_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1477-7525-3-61","volume":"3","author":"JJ Swigris","year":"2005","unstructured":"Swigris JJ, Stewart AL, Gould MK, Wilson SR (2005) Patients\u2019 perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 3:61. https:\/\/doi.org\/10.1186\/1477-7525-3-61","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"895_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1479972311416382","volume":"8","author":"G Schoenheit","year":"2011","unstructured":"Schoenheit G, Becattelli I, Cohen AH (2011) Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis 8(4):225\u2013231. https:\/\/doi.org\/10.1177\/1479972311416382","journal-title":"Chron Respir Dis"},{"key":"895_CR28","unstructured":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA) The Voice of the Patient. A series of reports from the U.S. Food and Drug Administration\u2019s (FDA\u2019s) Patient-Focused Drug Development Initiative. Idiopathic Pulmonary Fibrosis. Available at: https:\/\/www.fda.gov\/files\/about%20fda\/published\/The-Voice-of-the-Patient--Idiopathic-Pulmonary-Fibrosis.pdf. Accessed: 10 December 2024"},{"issue":"1","key":"895_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12931-023-02554-8","volume":"24","author":"F Amati","year":"2023","unstructured":"Amati F, Spagnolo P, Ryerson CJ, Oldham JM, Gramegna A, Stainer A, Mantero M, Sverzellati N, Lacedonia D, Richeldi L, Blasi F, Aliberti S (2023) Walking the path of treatable traits in interstitial lung diseases. Respir Res 24(1):251. https:\/\/doi.org\/10.1186\/s12931-023-02554-8","journal-title":"Respir Res"},{"key":"895_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12931-024-02997-7","volume":"25","author":"DE Hofman","year":"2024","unstructured":"Hofman DE, Magr\u00ec T, Moor CC, van Beek FT, G\u00fcr Y, Ooijevaar J, Wijsenbeek MS, de Mul M (2024) Patient-centered care in pulmonary fibrosis: access, anticipate, and act. Respir Res 25:395. https:\/\/doi.org\/10.1186\/s12931-024-02997-7","journal-title":"Respir Res"},{"issue":"6","key":"895_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1513\/AnnalsATS.201611-934OC","volume":"14","author":"YH Khor","year":"2017","unstructured":"Khor YH, Goh NSL, McDonald CF, Holland AE (2017) Oxygen therapy for interstitial lung disease. a mismatch between patient expectations and experiences. Ann Am Thorac Soc 14(6):888\u2013895. https:\/\/doi.org\/10.1513\/AnnalsATS.201611-934OC","journal-title":"Ann Am Thorac Soc"},{"issue":"169","key":"895_CR32","doi-asserted-by":"publisher","first-page":"230066","DOI":"10.1183\/16000617.0066-2023","volume":"32","author":"G Tikellis","year":"2023","unstructured":"Tikellis G, Hoffman M, Mellerick C, Burge AT, Holland AE (2023) Barriers to and facilitators of the use of oxygen therapy in people living with an interstitial lung disease: a systematic review of qualitative evidence. Eur Respir Rev 32(169):230066. https:\/\/doi.org\/10.1183\/16000617.0066-2023","journal-title":"Eur Respir Rev"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00895-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:21:39Z","timestamp":1782847299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00895-x","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Retrospective Open Access order has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SS, ALO and PL are employees of Boehringer Ingelheim Pharmaceuticals, Inc. ACS, MLN and LDS are faculty members of the Duke Clinical Research Institute, which receives funding support from Boehringer Ingelheim Pharmaceuticals, Inc to run the IPF-PRO\/ILD-PRO Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the Duke University Institutional Review Board (Pro00046131) and at every enrolling center (listed in the Acknowledgments). The protocol was approved by the relevant Institutional Review Boards and\/or local Independent Ethics Committees prior to patient enrollment at every site. All patients provided written consent prior to entering the registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"32"}}